[1] Gimbrone MA, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis[J]. Circ Res, 2016, 118: 620-636. [2] Fan LM, Cahill-Smith S, Geng L, et al. Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function[J]. Free Radical Biol Med, 2017, 108: 940-951. [3] Dehghan Shahreza F. From oxidative stress to endothelial cell dysfunction[J]. J Prev Epidemiol, 2016, 1: e04. [4] Vogel ME, Idelman G, Konaniah ES, et al. Bilirubin prevents atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice by inhibiting endothelial VCAM-1 and ICAM-1 signaling[J]. J Am Heart Assoc, 2017, 6: e004820.doi: 10.1161/JAHA.116.004820. [5] Song Z, Liu Y, Hao B, et al. Ginsenoside Rb1 prevents H2O2-induced HUVEC senescence by stimulating sirtuin-1 pathway[J]. PLoS One, 2014, 9: e112699.doi: 10.1371/journal.pone.0112699. [6] 周彬, 余舒杰, 刘定辉, 等. 人参皂苷Rb_1通过Caveolin-1/eNOS/NO通路抗人脐静脉内皮细胞衰老[J]. 中药材, 2019, 42: 189-195. [7] 宋志明, 余舒杰, 杨建涛, 等. 硫化氢通过调节Sirt1/eNOS信号通路延缓人脐静脉内皮细胞衰老[J]. 中国病理生理杂志, 2018, 34: 258-263. [8] Forstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of ather-osclerosis[J]. Circ Res, 2017, 120: 713-735. [9] 宋志明, 余舒杰, 焦洁, 等. 硫化氢通过抑制蛋白激酶B过度磷酸化延缓内皮细胞衰老[J].中国病理生理杂志, 2020, 36:652-656. [10] Qiao L, Zhang X, Liu M, et al. Ginsenoside Rb1 enhances atherosclerotic plaque stability by improving autophagy and lipid metabolism in macrophage foam cells[J]. Front Pharmacol, 2017,8:727. doi: 10.3389/fphar.2017.00727. [11] 宋志明, 余舒杰, 巩贵宏, 等. 人参皂苷Rb1通过抑制炎症反应及氧化应激改善老年小鼠内皮功能[J]. 中国实验诊断学, 2018, 22: 1066-1070. [12] Bus P, Scharpfenecker M, Van Der Wilk P, et al. The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes[J]. Diabetologia, 2017, 60: 1813-1821. |